Closing Market Summary: Another Day, Another Flat FinishThe S&P 500 (+0.1%) finished at a new record close (just barely), but the headline is much more exciting than the reality. Wednesday's session was rather quiet at the macro level with the benchmark index hovering within a seven-point range. The Nasdaq (+0.1%) also eked out another record close, its third of the week, while the Dow (-0.2%) settled a step below its unchanged mark. The Russell 2000 outperformed the major U.S. indices, adding 0.6%.
Investors shrugged off President Trump's unexpected firing of FBI director James Comey, even though some mainstream media outlets suggested that the event may forestall tax reform efforts. The CBOE Volatility Index (VIX 9.99, +0.03, +0.3%) remained at a historically low level at Wall Street's closing bell.
Crude oil's 3.1% advance secured the energy sector's (+1.1%) spot atop the day's leaderboard. The commodity rallied following the Energy Information Administration's weekly inventory report, which showed a larger than expected draw in U.S. crude stocks for the week ended March 5 (5.3 million barrels actual vs 2.0 million barrels consensus). WTI crude settled at $47.28/bbl.
Out of the ten remaining sectors, seven--financials (+0.3%), materials (+0.4%), technology (+0.4%), consumer staples (+0.1%), utilities (+0.2%), telecom services (+0.3%), and real estate (+0.6%)--finished in the green. The top-weighted technology sector's positive performance was underpinned by chipmakers, which rallied around NVIDIA's (NVDA 121.29, +18.35) upbeat earnings report. The company spiked 17.8% after reporting better than expected earnings/revenues and issuing positive guidance. The PHLX Semiconductor Index added 2.1%.
Conversely, the three laggards--consumer discretionary (-0.3%), industrials (-0.4%), and health care (-0.3%)--received no help on the earnings front. Walt Disney (DIS 109.66, -2.41) and Priceline (PCLN 1824.77, -86.36) weighed on the consumer discretionary sector, losing 2.2% and 4.5%, respectively. Both companies reported better than expected earnings, but PCLN missed top-line estimates and issued disappointing guidance.
Allergan (AGN 229.72, -8.79) was the worst-performing component in the health care sector, tumbling 3.7%, despite reporting upbeat earnings/revenues and providing positive guidance. Analysts at Goldman did downgrade AGN shares to 'Neutral' from 'Buy' on Wednesday morning, which contributed to the company's poor performance. Biotech names also weighed on the sector, evidenced by the 0.4% decrease in the iShares Nasdaq Biotechnology ETF (IBB 291.89, -1.06).
In the industrial sector, Boeing (BA 183.18, -2.31) took center stage following reports that the company halted 737 MAX flights for engine inspections. BA shares finished lower by 1.3%.
U.S. Treasuries hovered just above their flat lines for the majority of Wednesday's session, however, a late-afternoon downtick took them into the red. The benchmark 10-yr yield settled one basis point higher at 2.41%.
On the data front, investors received April Import/Export Prices, the April Treasury Budget, and the weekly MBA Mortgage Applications Index:
- Import prices excluding oil rose 0.3% in April after adding 0.2% in March. Export prices excluding agriculture increased 0.1% in April after rising 0.1% in March (revised from 0.2%).
- The key takeaway from the report is that it won't alter the market's current assumptions about the likely path of the Fed's monetary policy.
- The Treasury Budget for April showed a surplus of $182.4 billion versus a surplus of $106.5 billion for April 2016.
- The Treasury Budget data is not seasonally adjusted, so the April surplus cannot be compared to the $176.2 billion deficit registered in March.
- The weekly MBA Mortgage Applications Index increased 2.4% to follow last week's 0.1% downtick.
Tomorrow, market participants will receive April PPI (consensus 0.2%) and Initial Claims (consensus 242,000). Both reports will cross the wires at 8:30 ET.
- Nasdaq Composite +13.9% YTD
- S&P 500 +7.2% YTD
- Dow Jones Industrial Average +6.0% YTD
- Russell 2000 +3.1% YTD
![]()
Snap misses by $0.26 (GAAP), misses on revs (22.97 -0.35)
|
*BOEING TEMPORARILY SUSPENDS 737 MAX FLIGHTS ON ENGINE ISSUE
Walt Disney: Color on Quarter (112.07)
FBR reiterates Outperform; $116 tgt. Firm notes that DIS's F2Q17 featured EPS that were a little better than we had modeled: $1.50, up 10% YOY, versus our $1.45 estimate (and the $1.41 FactSet consensus). However, the call also featured slightly cautious commentary on key TV secular issues in advertising and pay TV subs, which could stoke concerns that tend to weigh on DIS and peer multiples.
Needham reiterates Hold. Firm notes for FY2Q17, DIS reported revenue of $13.336B, up 3% y/y and 1% below their estimates, and EPS of $1.50 (up 10% y/y and 7% above our estimates). What they liked most about the call was $200mm lower CapX guidance, raised share repurchases, and higher operating FCF. In the near term, for FY3Q17, DIS stated that Cable Network cost growth would be 16%, driven by a $400mm step-up in costs related to ESPN's new NBA deal, followed by another $200mm rise in FY4Q17. In addition, margins at Parks should be under pressure in 2H17 owing to Pandora opening in Orlando, and Star Wars lands, and Guardians in LA, a hotel in Hong Kong, Shanghai 1st quarter profits, and 18 days of dry dock for one of DIS's ships.
RBC reiterates Outperform; $130 tgt. Firm notes DIS provided a strong set of results including a 5% beat on OI, and they bring estimates up. However, the company noted modest acceleration in sub losses. They think this no longer poses a grave danger to the thesis given the strength of non-cable assets. They maintain their target as the narrative evolves.
Shares of Disney are trading 2.3% lower at $109.45/share in pre-market trading
Early premarket gappersGapping up:
- ESIO +23.5%, MNKD +18.8%, ANF +15.6%, ARRY +14.5%, SEDG +14.2%, RCM +14.1%, NVDA +12.1%, CUR +10.9%, ATHX +10.8%, REXX +10.6%, NAVB +9.8%, VSLR +8.8%, COHR +8.7%, EA +8.3%, HPJ +8.2%, COTY +7.6%, MTBC +7.1%, OCRX +7%, TRIP +6.2%, FAC +5.9%, VCEL +5.9%, IAG +5.6%, TRUE +5.4%, FBM +5.3%, AAXN +5.2%, CROX +5.2%, MCHP +4.9%, GSVC +4.6%, NBIX +4.4%, HEAR +4.3%, RPD +4.2%, GFI +3.8%, XELB +3.7%, AGI +3.5%, XOG +3.5%, CLDX +3.2%, SLD +3%, AMD +2.9%, YUME +2.8%, WIX +2.8%, SBGL +2.7%, NUAN +2.7%, YY +2.6%, BID +2.4%, EVRI +2.3%, AU +2%, ING +2%, TRCO +1.9%, GDX +1.6%, INGN +1.6%, AUXO +1.5%, ABX +1.4%, GDOT +1.4%, ATHM +1.4%, HPT +1.4%, BBL +1.2%, RIO +1.2%, BHP +1.1%, LEU +1.1%, INFI +1.1%, NVO +1%, HSBC +1%
Gapping down:
- YELP -26.7%, FOSL -22.9%, PLPM -16.7%, KRNT -15.9%, ACIA -13.8%, DEPO -13.5%, FUEL -12.3%, EKSO -10.5%, SSNI -10.4%, CLNT -10.1%, OPK -9.7%, TCX -9.5%, ZAYO -7.3%, TIME -6.6%, COGT -6.3%, EARN -5.7%, ZSAN -5.5%, MTRX -5.5%, SPWR -5.3%, MZOR -5.3%, ARNA -4.7%, XCO -4.7%, HALO -4.6%, AQMS -4.6%, DPW -4.5%, INN -4.2%, RICK -4.1%, ITEK -4.1%, ACAD -3.9%, PRI -3.8%, CXRX -3.7%, OREX -3.5%, AKBA -3.5%, AMID -3.5%, PCLN -3.2%, MATR -3.2%, JAZZ -3.1%, PEIX -2.9%, WSTC -2.5%, MIDD -2.5%, EGLT -2.4%, GERN -2.3%, X -2.1%, DIS -2.1%, SLF -1.7%, LSCC -1.6%, SAGE -1.6%, OCLR -1.5%, COKE -1.5%, CLNS -1.4%, AGN -1.3%, AGN -1.3%, PSEC -1.3%, SUPN -1.2%, W -1.1%, WFC -1.1%, WAIR -1.1%, LITE -1%, IPHI -1%, GWPH -1%
May 10, 2017
MAKOR - WIX (Wix.com) 1Q17 results - Record Premium subscriptions adds; FY17 guidance is raised - first take;
• Revenues for 1Q17 of $92.5m above street consensus of $90.4m, an increase of 50% compared with 1Q16 and 10% sequentially. 1Q17 collections increased by 51% compared with 1Q16 and 17% sequentially.• Record Premium subscriptions additions - added 208k net premium subscriptions in the period to reach 2.7 million as of March 31, 2017, a 38% increase over the prior year (in 1Q16 the company added 170k premium subscriptions). Positive momentum in the users cohorts continues.• Registered user growth – the company added 5.9 million registered users in the first quarter to reach 103 million as of March 31, 2017, a 25% increase compared to the prior year;• Free Cash Flow for 1Q17 of $14.8m above street expectation of $12.9m (and vs $ -2.1m in 1Q16), reflecting the continued strong operational leverage of the business.• Non GAAP loss per share of ($0.18) below street consensus of (-$0.13).• 2Q17 guidance – management guides 2Q revenues in the range of $101-$102 slightly above street consensus of $100.6m (47.5% y/y growth at mid-point), and collections in the range of $116-$117 million (43% y/y growth at mid-point)• FY2017 guidance is raised – management raises full year guidance and expects revenues in the range of $421m-$423m (up from $417m-$419m) above street consensus of $419m, collections in the range of $473m-$477m (up from $461m-$467m ) and Non GAAP free cash flow in the range of $67-$68 million (up from $63-$64 million).• The company plans to launch a closed beta of a new major product in June and publicly reveal the product in the following months.• Management will host a call at 8:30 a.m. ET. We expect management to provide more details regarding current business trends and new products launch.Dial number: 866-393-4306 (US/Canada), 734-385-2616 (International) or 1-809-315-362 (Israel).We currently have a Hold rating on WIX with $64 PT (current price $74.15) - Update to follow.
Makor Capital11 Menachem Begin St., 26th FLRamat Gan 52681
ISRAEL
Tel +972 3 5453 762Fax +972 3 7162 680Research DisclaimerThis publication has been prepared by Makor Capital Limited (“Makor Capital”) and is intended for professional or qualified investors only. Makor Securities London Ltd (“Makor Securities”)is distributing this material to its clients who are Eligible Counterparties or Professional Clients under FCA Rules. It may also be disseminated to persons who are Investment Professionals within the meaning of the Financial Services and Markets Act 2000 (Financial Promotion Order 2005). In the United States, Makor Capital only distributes this material to major US institutional investors (as that term is defined in Rule 15a-6 of the Securities and Exchange Act of 1934) and to SEC-registered broker-dealers or banks acting in a broker–dealer capacity. This material is not intended for distribution to any other persons and should not be redistributed. If you do not fall into any of these categories you should disregard it.This material is a marketing communication. It is not investment research and has not been prepared in accordance with legal requirements designed to promote the independence of investment research. It is not subject to any prohibition on dealing ahead of the dissemination of investment research under U.K. law. This material is not a research report and is not intended to be a research report as defined under U.S. securities laws and regulations. This material is not intended to provide information reasonably sufficient upon which to base any investment decision.This material does not take into account the particular investment objectives, financial situation or needs of individual clients or other recipients. Before acting on this material, clients and other recipients should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice.This material should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action.In the United States, Makor Capital does not offer securities services to U.S. persons except pursuant to SEC Rule 15a-6 only to major US institutional investors and SEC registered broker-dealers or banks acting in a broker–dealer capacity. Transactions in the United States must be effected through the U.S. broker-dealer, Oscar Gruss & Son Incorporated. Oscar Gruss & Son has not prepared, reviewed or distributed this material.Some of this material is produced by providers which Makor Securities believes to be reliable, but Makor Securities does not warrant or represent (expressly or impliedly) that it is accurate, complete, not misleading or as to its fitness for the purpose intended and it should not be relied upon as such.Opinions expressed will be the current opinions of those producing this material as of the date appearing on this material only. We expect those producing the material in this publication to update it on a timely basis but can give no undertaking that they will do so and regulatory compliance or other reasons may prevent them from doing so (or us from disseminating updated material).Members and employees of Makor Securities London Ltd, employees of Makor Capital, Makor Capital Markets may from time to time have long or short positions in securities, warrants, futures, options, derivatives or other financial instruments referred to in this material. For Makor Securities, this information is set out in our Conflicts of Interest Policy which is available on request. Policies for the production of research from other research providers are available on request. Unless otherwise stated, share prices provided within this material are as at the close of business on the day prior to the date of the material.Neither the whole nor any part of this material may be duplicated in any form or by any means. Neither should any of this material be redistributed or disclosed to anyone without prior consent. This material is issued for general information and discussion purposes only. None of Makor Securities, Makor Capital, Makor Capital Markets accepts liability whatsoever for any direct, indirect or consequential loss or damage of any kind arising out of the use of all or any of this material.The services, securities and investments discussed in this material may not be available to, nor are suitable for all investors. Investors should make their own investment decisions based upon their own financial objectives and financial resources and it should be noted that investment involves risk, including the risk of capital loss. Past performance is no guide to future performance. In relation to securities denominated in foreign currency, movements in exchange rates will have an effect on the value, either favourable or unfavourable.All investors. Investors should make their own investment decisions based upon their own financial objectives and financial resources and it should be noted that investment involves risk, including the risk of capital loss. Past performance is no guide to future performance. In relation to securities denominated in foreign currency, movements in exchange rates will have an effect on the value, either favourable or unfavourable.EntitiesMakor Securities London Ltd is authorised and regulated by the Financial ConductAuthority (FCA registration number 625054)Makor Capital, company number 514456466, is incorporated in Israel and is a 100% heldsubsidiary of Makor Holdings Pte Ltd incorporated in Singapore.Makor Capital Markets SA, company number CH-660.2.999.011-0 is incorporated in Switzerlandand is also a 100% held subsidiary of Makor Holdings Pte Ltd.
Having trouble viewing this email? Click here
This email was sent to lchekroun@makor-cm.com by Research@Makor-Capital.com
Update Profile/Email Address | Unsubscribe | Report abuse
Smoove email marketing
>>> Up
*AB Foods Raised to Buy at Citi, PT 3,400p
*Air France-KLM Raised to Equal-weight at Barclays, PT EU10
*Coach Raised to Buy at Goldman
*Kloeckner Raised to Hold at Baader-Helvea, PT EU10
*Victoria Raised to Buy at Finncap, PT GBP5
>>> Down
*Akzo Nobel Cut to Market Perform at Bernstein, PT EU82
*Card Factory Cut to Neutral at UBS, PT 320p
*Endesa Cut to Underperform at MainFirst, PT EU20
*Fraport Cut to Hold at DZ Bank, PT EU72
*Gem Diamonds Cut to Hold at Liberum, PT 90p
*H&M Cut to Hold at Jefferies, PT SEK235
*Saipem Cut to Hold at Jefferies, PT EU0.38
*Vestas Cut to Neutral at Macquarie
*Vinci Cut to Hold at SocGen
*Zalando Cut to Hold at DZ Bank, PT EU42
>>> Initiation
*Aker BP New Outperform at Exane, PT NOK175
*Sipef New Buy at Berenberg, PT EU82
>>> Call
>> Stock
*ZALANDO REMOVED FROM CONVICTION BUY LIST AT GOLDMAN; STILL BUY
Dow -0.17% S&P -0.10% Nasdaq +0.29% Russell +0.02%
Nasdaq (+0.3%) opened Tuesday's session in positive territory and never looked back, settling at a new record high. Blue Chip stocks closed lower becasue of financials. Following a small relief rally yesterday, crude oil returned to its bearish ways, dropping 1.2% to $45.88/bbl. The slip left the energy sector (-0.9%) with the utilities space (-0.9%) at the bottom of the leaderboard. Financials' late-afternoon tumble coincided with the broader market slipping to a fresh low in response to a Sky News interview with North Korea's ambassador to the UK Choe Il. The North Korean ambassador said his country will proceed with its 6th nuclear test when it is deemed appropriate by Supreme Leader Kim Jong-un. US After Hours NVDA +11%, COHR +9%, EA +8%, TRIP +6.5%, MCHP +5%, NUAN +2% higher following earnings/guidance... YELP -28%, FOSL -22%, ACIA -15%, DIS / PCLN -3% lower following earnings/guidance, optical names lower. Asian stocks resumed a rally as Hong Kong shares jumped to a 21-month high. U.S. stock-index futures slipped as Donald Trump fired FBI Director James Comey, while the yen rose on concern over North Korea’s nuclear program. Chinese companies listed across the border climbed amid signs of stability in the Shanghai market.
Nikkei +0.29% Hang Seng +1.08% CSI +0.38% Shanghai +0.10%
Eur$ 1.0888 WTI $46.18
S&P -0.15%
Macro :
- Fed’s Rosengren: Balance-Sheet Normalization Won’t Be Disruptive
- Fed’s Rosengren Sees Risk of Shock From Commercial Real Estate
- China April Consumer Prices +1.2% Y/y; Est. +1.1%
Keep an eye on :
- ABI BB : AB InBev Zone President Asia Pacific North Buys $5.96m of ADRs
- AH NA : Ahold Delhaize 1Q Free Cash Flow EU197m, Ahold Delhaize 1Q Profit Beats Est., Sees U.S. Inflation in 2H
- AIR FP : Airbus Helicopters Sees Market Stabilizing After Slump: Echos
- AF FP : Air France-KLM April Passengers Rise 8.5% to 8.4m
- CS FP : Axa 1Q Revenue EU31.6b vs Restated EU31.7b, Axa Says It Intends to IPO Its U.S. Operations
- CRG IM : Banca Carige 1Q Common Equity Tier 1 Ratio 10.9%
- BLT LN : BHP Says Copper Mine Sale Plan Shows Actively Managing Portfolio
- BMW GY : BMW Plans to Boost Output Capacity to 3 Mln Cars in 5 Years: HB
- AFX GY : Carl Zeiss Meditec Sees FY Ebit Margin 13% To 15%
- CLLN LN : Bid Rumor in the city after promising start of the year - Telegraph
- CBK GY : Commerzbank Plans Most Job Cuts in Corporate Banking Unit: HB
- DAI GY : Daimler Drops Bid to Sell 2017 Mercedes U.S. Diesels: Reuters
- BN FP : Yili Said to Make ~$850m Bid for Danone-Owned Stonyfield: NYP
- DGE LN : Diageo Expects FY Net Sales Growth in Line With 1H’s 4.4%
- EDF FP : EDF 1Q Revenue EU21.1b, EDF Seeks to Discuss New Nuclear Rules With President-Elect
- FGR FP : Eiffage 1Q Revenue EU3.22b
- GLEN LN : Glencore Said to Hire StanChart for Australian Coal Mine Sale
- HEI GY : Heidelbergcement 1Q Profit Misses, Confirms 2017 Outlook
- HIK LN : Hikma’s Generic Advair Likely Delayed, Express Scripts Says
- HMB SS : Norway Oil Fund Sold Close to SEK4b H&M Shares in 1Q: DI
- HOT GY : Hochtief Confirms Outlook; Gets S&P Investment Grade BBB Rating
- ING NA : ING 1Q Underlying Pretax Profit Beats Highest Est.
- LR FP : Legrand 1Q Sales EU1.32b; Confirms 2017 targets
- LIN GY : Linde Chairman Sees Praxair Finalized in Weeks, Not Months: Rtrs
- MS IM : Mediaset Sees Positive FY Op. Profit, Consolidated Net Results
- KN FP : Natixis 1Q Net EU280M; Est. EU254M, Natixis 1Q ‘Good As Always’ as Investment Banking Drives Beat
- NOEJ GY : Norma 1Q Sales Beat Highest Est.
- OVS GY : OVS Shares Likely to Price at EU6.11 Each in Placement: Terms
- ROG VX : Roche’s Genentech: Tecentriq Cancer Drug Fails Phase III Test
- P1Z GY : Patrizia Immobilien Sees FY Operating Income EU60m To EU75m
- SFL IM : Safilo Group 1Q Gross Profit EU116.8m vs EU184.2m Year Ago
- SALM NO : Salmar 1Q Operating Revenue Beats Est.
- SBMO NO : SBM Offshore 1Q Revenue $435m
- SEV FP : Suez 1Q Ebit Up LFL 2.6% to EU281m; Reaffirms 2017 Targets, Suez to Work With L’Oreal on Environmental Performance
- SIX2 GY : Sixt Leasing 1Q Revenue EU187.7m
- 9984 JP : SoftBank Said to Eye Up to $95B Fund Close as Soon as Next Week
- SYNN VX : ChemChina Min. Acceptance Condition for Syngenta Stock Satisfied
- TGS NO : TGS Reports 1Q Unexpected Profit
- VOLVB SS : Volvo Hasn’t Yet Decided If VCE Belongs in Group Long Term: DI
- WIE GY : Wienerberger 1Q Revenue EU659.6m